Ho-ho-ho! Gather ’round, my merry friends, for a tale not of elves and reindeer, but of a challenge faced in the land far from the North Pole. It’s a story about the tricky business of prescribing opioids in the United States, where the jolly old Saint Nick of good health is wrestling with a rather naughty epidemic.

Once upon a recent time, doctors have been writing fewer opioid prescriptions, yet the epidemic, like a stubborn chimney soot, refuses to clear. The data, like a list of who’s naughty or nice, shows a sleigh-load of opioid-related deaths, with the mischievous elf named Illicit Fentanyl causing most of the trouble. And would you believe it, there’s no clear trail of cookie crumbs linking the number of prescriptions or the strength of the doses to hospitalizations or the grim tally of deaths.

In 2016, the wise old sages at the Centers for Disease Control and Prevention (CDC) issued guidelines, hoping to guide the sleigh on a safer path. But, oh, what a tangle of Christmas lights this became! It seems these guidelines may have led to more hospital visits and a spike in mental health concerns, as patients were weaned off their medications faster than reindeer take flight.

Amidst this blizzard, a fourth wave of the opioid epidemic is emerging, like an unexpected snowstorm on Christmas Eve, partly due to the complications brought on by the global scrooge, COVID-19.

But fear not, for there is hope twinkling like the star atop the Christmas tree. A panel of multidisciplinary experts, as diverse as the toys in Santa’s workshop, have come together to craft new guidelines for prescribing opioids for chronic non-cancer pain. They’ve checked their list twice, conducting a systematic review of the evidence, and have come up with 20 recommendations, wrapped up with a bow of over 90% agreement.

These guidelines are divided into four sections, like the four quarters of a gingerbread cookie: initial steps of opioid therapy, assessing the effectiveness, monitoring adherence and side effects, and final phase recommendations. They’re designed to ensure that opioids are given out like presents to those who truly need them, in low doses, with careful monitoring, and only to those who show real improvement in pain relief and daily function.

However, the story isn’t over, as there’s still a shortage of literature on long-term opioid therapy for chronic non-cancer pain, and biases in guideline preparation are as common as fruitcake at a holiday party. The rules vary across the states like the many different traditions of Christmas around the world.

In conclusion, my dear friends, the new guidelines are like a map for Santa’s sleigh, guiding it safely through the night. They recommend that chronic opioid therapy should be a carefully considered gift, given with a clear understanding of the risks and benefits, to ensure a merry and pain-free existence for all. And with that, I wish you all a healthy and joyful season, with hopes that the New Year brings better management of this challenging epidemic. Ho-ho-ho! 🎅🎄